Multidimensional Geriatric Pain Assessment

March 4, 2021 updated by: AKİF BULUT, Uludag University

Determining the Effectiveness of the Geriatric Pain Measure ın Older Adults Attending a Gynecology Clinic

This descriptive study was conducted on 100 patients who applied to the gynecology outpatient clinic to determine the effectiveness of the Geriatric Pain Measure (GPM) in elderly individuals. The data of the study were collected using the Patient Information Form, the GPM, and the Standardized Mini Mental State Examination (SMMSE). The mean GPM score of the elderly individuals, who had an average age of 70 (65-90), was found to be 27.37 (0-88), the sub-dimension mean scores were 9.52 (0-49.9), 7.14 (0-14.2), 4.76 (0-9.5), 2.38 (0-11.9), and 4.76 (0-11.9) respectively. It was determined that 54% of the patients had mild pain (0-29), 38% of them had moderate pain (30-69), and 8% of them had severe pain (70 and above). The findings of the present study were similar to the results of numerous other studies in which both the same scale and different scales were used to assess pain in elderly individuals.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Bursa, Turkey, 16000
        • Bursa Province Public Hospitals Union General Secretariat Health Sciences University Bursa High Specialization Education and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Female patients 65 years of age or older who applied to gynecology clinic.

Description

Inclusion Criteria:

  • 65 years and older patients,
  • Scoring 23 or above in the Standardized Mini Mental State Examination,
  • Have no obstacle to answering questions,
  • Not addicted to alcohol or other substances,
  • No trauma in the last six months.

Exclusion Criteria:

  • Patients younger than 65,
  • Scoring less than 23 points in the Standardized Mini Mental State Examination,
  • Who have a situation that prevents them from answering questions,
  • Are addicted to alcohol or other substances,
  • Trauma in the last six months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determining the pain levels of patients aged 65 and over
Time Frame: 4 months
The Geriatric Pain Measure is a 24-item multidimensional scale developed by Ferrell et al. (2000), for elderly individuals treated on an outpatient basis. Its validity and reliability in Turkish were confirmed by Dursun and Bektaş (2017). The Turkish version of the scale has five sub-dimensions: withdrawal due to pain (Factor 1; Items 19, 20, 22, 23); pain intensity (Factor 2; Items 1, 2, 3, 4, 5, 6); pain with movement (Factor 3; Items 9, 10, 11, 12); pain with strenuous activities (Factor 4; Items 7, 8, 18, 21, 24); and pain with other activities (Factor 5; Items 13, 14, 15, 16, 17). The total score is calculated by adding the "Yes" answers, and each item is multiplied by 2.38 and the total is converted into a score of between 0 and 100. Scores between 0 and 29 are considered to indicate mild pain, scores between 30 and 69 are considered to indicate moderate pain, and scores of 70 and above are considered to indicate severe pain.
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Uludag University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2018

Primary Completion (Actual)

November 1, 2019

Study Completion (Actual)

November 1, 2019

Study Registration Dates

First Submitted

March 2, 2021

First Submitted That Met QC Criteria

March 4, 2021

First Posted (Actual)

March 9, 2021

Study Record Updates

Last Update Posted (Actual)

March 9, 2021

Last Update Submitted That Met QC Criteria

March 4, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • ABULUT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

In the work permit obtained from Bursa Provincial Health Directorate, it was stipulated that the study data should not be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe